A Predictive High-Throughput Scale-Down Model of Monoclonal Antibody Production in CHO Cells

被引:72
作者
Legmann, Rachel [1 ]
Schreyer, H. Brett [1 ,2 ]
Combs, Rodney G. [3 ]
McCormick, Ellen L. [3 ]
Russo, A. Peter [1 ]
Rodgers, Seth T. [1 ]
机构
[1] Seahorse Biosci Inc, Billerica, MA 01862 USA
[2] Genomatica Inc, San Diego, CA USA
[3] Pfizer Inc, Chesterfield, MO USA
关键词
bioprocess development; high-throughput cell culture automation; Quality by Design; fed-batch parallel micro-bioreactors; monoclonal antibody; scale-up; HOLLOW-FIBER BIOREACTORS; FED-BATCH CULTURE; DESIGN; GROWTH; GLYCOSYLATION; VALIDATION; MICROCHIP; QUALITY; SYSTEM;
D O I
10.1002/bit.22474
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Multi-factorial experimentation is essential in understanding the link between mammalian cell culture conditions and the glycoprotein product of any biomanufacturing process. This understanding is increasingly demanded as bioprocess development is influenced by the Quality by Design paradigm. We have developed a system that allows hundreds of micro-bioreactors to be run in parallel under controlled conditions, enabling factorial experiments of much larger scope than is possible with traditional systems. A high-throughput analytics workflow was also developed using commercially available instruments to obtain product quality information for each cell culture condition. The micro-bioreactor system was tested by executing a factorial experiment varying four process parameters: pH, dissolved oxygen, feed supplement rate, and reduced glutathione level. A total of 180 micro-bioreactors were run for 2 weeks during this DOE experiment to assess this scaled down micro-bioreactor system as a high-throughput tool for process development. Online measurements of pH, dissolved oxygen, and optical density were complemented by of fine measurements of glucose, viability, titer, and product quality. Model accuracy was assessed by regressing the micro-bioreactor results with those obtained in conventional 3 L bioreactors. Excellent agreement was observed between the micro-bioreactor and the bench-top bioreactor. The micro-bioreactor results were further analyzed to link parameter manipulations to process outcomes via leverage plots, and to examine the interactions between process parameters. The results show that feed supplement rate has a significant effect (P < 0.05) on all performance metrics with higher feed rates resulting in greater cell mass and product titer. Culture pH impacted terminal integrated viable cell concentration, titer and intact immunoglobulin G titer, with better results obtained at the lower pH set point. The results demonstrate that a micro-scale system can be an excellent model of larger scale systems, while providing data sets broader and deeper than are available by traditional methods. Biotechnol. Bioeng. 2009; 104: 1107-1120. (C) 2009 Wiley Periodicals, Inc.
引用
收藏
页码:1107 / 1120
页数:14
相关论文
共 49 条
[1]  
ALTEN R, 2008, ARTHRITIS RES THER, V10, P1
[2]   Production technologies for monoclonal antibodies and their fragments [J].
Andersen, DC ;
Reilly, DE .
CURRENT OPINION IN BIOTECHNOLOGY, 2004, 15 (05) :456-462
[3]   Miniature bioreactors: current practices and future opportunities [J].
Betts, Jonathan I. ;
Baganz, Frank .
MICROBIAL CELL FACTORIES, 2006, 5 (1)
[4]   Protein sizing on a microchip [J].
Bousse, L ;
Mouradian, S ;
Minalla, A ;
Yee, H ;
Williams, K ;
Dubrow, R .
ANALYTICAL CHEMISTRY, 2001, 73 (06) :1207-1212
[5]   Animal cell cultures: recent achievements and perspectives in the production of biopharmaceuticals [J].
Butler, M .
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2005, 68 (03) :283-291
[6]   Sialic acids: carbohydrate moieties that influence the biological and physical properties of biopharmaceutical proteins and living cells [J].
Byrne, Barry ;
Donohoe, Gerard G. ;
O'Kennedy, Richard .
DRUG DISCOVERY TODAY, 2007, 12 (7-8) :319-326
[7]   Twenty-Four Well Plate Miniature Bioreactor System as a Scale-Down Model for Cell Culture Process Development [J].
Chen, Aaron ;
Chitta, Rajesh ;
Chang, David ;
Anianullah, Ashraf .
BIOTECHNOLOGY AND BIOENGINEERING, 2009, 102 (01) :148-160
[8]   Microchip assays for screening monoclonal antibody product quality [J].
Chen, Xiaoyu ;
Tang, Kaiyan ;
Lee, Maximilian ;
Flynn, Gregory C. .
ELECTROPHORESIS, 2008, 29 (24) :4993-5002
[9]   Application of factorial design to accelerate identification of CHO growth factor requirements [J].
Chun, C ;
Heineken, K ;
Szeto, D ;
Ryll, T ;
Chamow, S ;
Chung, JD .
BIOTECHNOLOGY PROGRESS, 2003, 19 (01) :52-57
[10]  
Cogdill RP., 2008, Journal of Pharmaceutical Innovation, V3, P23, DOI [10.1007/s12247-008-9025-3, DOI 10.1007/s12247-008-9025-3, DOI 10.1007/S12247-008-9025-3]